REPORT ID 4031

Global Transthyretin Market Research Report 2017

Publish Date
15-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the global Transthyretin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Transthyretin in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Transthyretin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Alnylam Pharmaceuticals Inc
    Arcturus Therapeutics Inc
    Ionis Pharmaceuticals Inc
    Neurimmune Holding AG
    Pfizer Inc
    Prothena Corp Plc
    Regeneron Pharmaceuticals Inc
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    AG-10
    ALN-TTRsc02
    CRX-1008
    EDE-1307
    Inotersen Sodium
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Familial Amyloid Neuropathies
    Alzheimer's Disease
    Cardomyopathy
    Neuropathy
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Transthyretin Market Research Report 2017
1 Transthyretin Market Overview
    1.1 Product Overview and Scope of Transthyretin
    1.2 Transthyretin Segment by Type (Product Category)
        1.2.1 Global Transthyretin Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Transthyretin Production Market Share by Type (Product Category) in 2016
        1.2.3 AG-10
        1.2.4 ALN-TTRsc02
        1.2.5 CRX-1008
        1.2.6 EDE-1307
        1.2.7 Inotersen Sodium
        1.2.8 Others
    1.3 Global Transthyretin Segment by Application
        1.3.1 Transthyretin Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Familial Amyloid Neuropathies
        1.3.3 Alzheimer's Disease
        1.3.4 Cardomyopathy
        1.3.5 Neuropathy
        1.3.6 Others
    1.4 Global Transthyretin Market by Region (2012-2022)
        1.4.1 Global Transthyretin Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Transthyretin (2012-2022)
        1.5.1 Global Transthyretin Revenue Status and Outlook (2012-2022)
        1.5.2 Global Transthyretin Capacity, Production Status and Outlook (2012-2022)

2 Global Transthyretin Market Competition by Manufacturers
    2.1 Global Transthyretin Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Transthyretin Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Transthyretin Production and Share by Manufacturers (2012-2017)
    2.2 Global Transthyretin Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Transthyretin Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Transthyretin Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Transthyretin Market Competitive Situation and Trends
        2.5.1 Transthyretin Market Concentration Rate
        2.5.2 Transthyretin Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Transthyretin Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Transthyretin Capacity and Market Share by Region (2012-2017)
    3.2 Global Transthyretin Production and Market Share by Region (2012-2017)
    3.3 Global Transthyretin Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Transthyretin Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Transthyretin Consumption by Region (2012-2017)
    4.2 North America Transthyretin Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Transthyretin Production, Consumption, Export, Import (2012-2017)
    4.4 China Transthyretin Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Transthyretin Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Transthyretin Production, Consumption, Export, Import (2012-2017)
    4.7 India Transthyretin Production, Consumption, Export, Import (2012-2017)

5 Global Transthyretin Production, Revenue (Value), Price Trend by Type
    5.1 Global Transthyretin Production and Market Share by Type (2012-2017)
    5.2 Global Transthyretin Revenue and Market Share by Type (2012-2017)
    5.3 Global Transthyretin Price by Type (2012-2017)
    5.4 Global Transthyretin Production Growth by Type (2012-2017)

6 Global Transthyretin Market Analysis by Application
    6.1 Global Transthyretin Consumption and Market Share by Application (2012-2017)
    6.2 Global Transthyretin Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Transthyretin Manufacturers Profiles/Analysis
    7.1 Alnylam Pharmaceuticals Inc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Transthyretin Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Alnylam Pharmaceuticals Inc Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Arcturus Therapeutics Inc
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Transthyretin Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Arcturus Therapeutics Inc Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Ionis Pharmaceuticals Inc
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Transthyretin Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Ionis Pharmaceuticals Inc Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Neurimmune Holding AG
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Transthyretin Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Neurimmune Holding AG Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Pfizer Inc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Transthyretin Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Pfizer Inc Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Prothena Corp Plc
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Transthyretin Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Prothena Corp Plc Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Regeneron Pharmaceuticals Inc
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Transthyretin Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Regeneron Pharmaceuticals Inc Transthyretin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    ...

8 Transthyretin Manufacturing Cost Analysis
    8.1 Transthyretin Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Transthyretin

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Transthyretin Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Transthyretin Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Transthyretin Market Forecast (2017-2022)
    12.1 Global Transthyretin Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Transthyretin Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Transthyretin Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Transthyretin Price and Trend Forecast (2017-2022)
    12.2 Global Transthyretin Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Transthyretin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Transthyretin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Transthyretin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Transthyretin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Transthyretin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Transthyretin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Transthyretin Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Transthyretin Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer